Date Filed | Type | Description |
03/17/2023 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Sold 269 shares
@ $43.92, valued at
$11.8k
Sold 13,656 shares
@ $44.46, valued at
$607.1k
Exercised 13,925 options to buy
@ $14, valued at
$195k
|
|
12/05/2022 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 1,055 shares
@ $44.33, valued at
$46.8k
|
|
11/28/2022 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 21,000 shares
@ $0 Granted 45,000 options to buy
@ $45, valued at
$2M
|
|
02/15/2022 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 615 shares
@ $0 Granted 2,419 shares
@ $0 Paid exercise price by delivering 953 shares
@ $62.49, valued at
$59.6k
|
|
12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/23/2021 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 6,800 shares
@ $0 Granted 28,400 options to buy
@ $75.33, valued at
$2.1M
|
|
01/28/2021 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Exercised 5,149 options to buy
@ $14.18, valued at
$73k
Exercised 3,672 options to buy
@ $11.77, valued at
$43.2k
Exercised 4,872 options to buy
@ $11.77, valued at
$57.3k
|
|
12/16/2020 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 1,540 shares
@ $42.52, valued at
$65.5k
Exercised 5,250 restricted stock units
@ $0 |
|
11/20/2020 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 7,600 shares
@ $0 Granted 30,800 options to buy
@ $43.57, valued at
$1.3M
|
|
02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2020 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 2,331 shares
@ $63.88, valued at
$148.9k
Exercised 5,250 restricted stock units
@ $0 |
|
11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2019 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Sold 5,910 shares
@ $103.3211, valued at
$610.6k
Sold 4,090 shares
@ $103.8368, valued at
$424.7k
|
|
02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/20/2018 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 20,000 options to buy
@ $81.2, valued at
$1.6M
|
|
02/13/2018 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 2,600 shares
@ $0 Granted 6,269 shares
@ $0 Paid exercise price by delivering 2,666 shares
@ $76.845, valued at
$204.9k
|
|
11/21/2017 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 23,500 options to buy
@ $48.52, valued at
$1.1M
|
|
04/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/29/2016 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 3,478 options to buy
@ $14, valued at
$48.7k
|
|
07/22/2016 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 3,484 options to buy
@ $14, valued at
$48.8k
|
|
01/20/2016 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Exercised 13,921 options to buy
@ $2.5429, valued at
$35.4k
Exercised 5,800 options to buy
@ $2.5429, valued at
$14.7k
Exercised 23,201 options to buy
@ $2.5429, valued at
$59k
|
|
01/11/2016 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 3,478 options to buy
@ $14, valued at
$48.7k
|
|
01/05/2016 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Exercised 50,723 options to buy
@ $2.9739, valued at
$150.8k
Exercised 13,921 options to buy
@ $1.9826, valued at
$27.6k
Exercised 13,921 options to buy
@ $1.5085, valued at
$21k
|
|
11/24/2015 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Granted 33,000 options to buy
@ $31.42, valued at
$1M
|
|
08/11/2015 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Sold 2,150 shares
@ $42.5658, valued at
$91.5k
Sold 1,600 shares
@ $43.3544, valued at
$69.4k
|
|
07/14/2015 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Sold 3,120 shares
@ $46.2374, valued at
$144.3k
Sold 630 shares
@ $46.5616, valued at
$29.3k
|
|
06/15/2015 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Sold 3,750 shares
@ $42.4706, valued at
$159.3k
|
|
06/08/2015 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Sold 10,750 shares
@ $42.0151, valued at
$451.7k
|
|
05/12/2015 |
4
| Or Yat Sun (Chief Scientific Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns:
| Sold 8,000 shares
@ $36.1306, valued at
$289k
|
|
01/06/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|